
1. lancet haematol. 2018 aug;5(8):e333-e345. doi: 10.1016/s2352-3026(18)30107-8.
epub 2018 jul 20.

human candidate gene polymorphisms risk severe malaria children in
kilifi, kenya: case-control association study.

ndila cm(1), uyoga s(2), macharia aw(2), nyutu g(2), peshu n(2), ojal j(2), shebe
m(2), awuondo ko(2), mturi n(2), tsofa b(2), sepúlveda n(3), clark tg(4), band
g(5), clarke g(5), rowlands k(5), hubbart c(5), jeffreys a(5), kariuki s(6),
marsh k(2), mackinnon m(7), maitland k(8), kwiatkowski dp(9), rockett ka(5),
williams tn(10); malariagen consortium.

collaborators: abathina a, abubakar i, achidi e, agbenyega t, aiyegbo m, akoto a,
allen a, allen s, amenga-etego l, amodu f, amodu o, anchang-kimbi j, ansah n,
ansah p, ansong d, antwi s, anyorigiya t, apinjoh t, asafo-agyei e, asoala v,
atuguba f, auburn s, bah a, bamba k, bancone g, band g, barnwell d, barry a,
bauni e, besingi r, bojang k, bougouma e, bull s, busby g, camara a, camara l,
campino s, carter r, carucci d, casals-pascual c, ceesay n, ceesay p, chau t,
chuong l, clark t, clarke g, cole-ceesay r, conway d, cook k, cook o, cornelius
v, corran p, correa s, cox s, craik r, danso b, davis t, day n, deloukas p,
dembele a, devries j, dewasurendra r, diakite m, diarra e, dibba y, diss a,
djimdé a, dolo a, doumbo o, doyle a, drakeley c, drury e, duffy p, dunstan s,
ebonyi a, elhassan a, elhassan i, elzein a, enimil a, esangbedo p, evans j, evans
j, farrar j, fernando d, fitzpatrick k, fullah j, garcia j, ghansah a, gottleib
m, green a, hart l, hennsman m, hien t, hieu n, hilton e, hodgson a, horstmann r,
hubbart c, hughes c, hussein a, hutton r, ibrahim m, ishengoma d, jaiteh j,
jallow m, jallow m, jammeh k, jasseh m, jeffreys a, jobarteh a, johnson k, joseph
s, jyothi d, kachala d, kamuya d, kanyi h, karunajeewa h, karunaweera n, keita m,
kerasidou a, khan a, kivinen k, kokwaro g, konate a, konate s, koram k,
kwiatkowski d, laman m, le s, leffler e, lemnge m, lin e, ly a, macharia a,
macinnis b, mai n, makani j, malangone c, mangano v, manjurano a, manneh l,
manning l, manske m, marsh k, marsh v, maslen g, maxwell c, mbunwe e, mccreight
m, mead d, mendy a, mendy a, mensah n, michon p, miles a, miotto o, modiano d,
mohamed h, molloy s, molyneux m, molyneux s, moore m, moyes c, mtei f, mtove g,
mueller i, mugri r, munthali a, mutabingwa t, nadjm b, ndi a, ndila c, newton c, 
niangaly a, njie h, njie j, njie m, njie m, njie s, njiragoma l, nkrumah f,
ntunthama n, nyika a, nyirongo v, o'brien j, obu h, oduro a, ofori a, olaniyan s,
olaosebikan r, oluoch t, omotade o, oni o, onykwelu e, opi d, orimadegun a,
o'riordan s, ouedraogo i, oyola s, parker m, pearson r, pensulo p, peshu n, phiri
a, phu n, pinder m, pirinen m, plowe c, potter c, poudiougou b, puijalon o, quyen
n, ragoussis i, ragoussis j, rasheed o, reeder j, reyburn h, riley e, risley p,
rockett k, rodford j, rogers j, rogers w, rowlands k, ruano-rubio v,
sabally-ceesay k, sadiq a, saidy-khan m, saine h, sakuntabhai a, sall a, sambian 
d, sambou i, sanjoaquin m, sepúlveda n, shah s, shelton j, siba p, silva n,
simmons c, simpore j, singhasivanon p, sinh d, sirima s, sirugo g, sisay-joof f, 
sissoko s, small k, somaskantharajah e, spencer c, stalker j, stevens m,
suriyaphol p, sylverken j, taal b, tall a, taylor t, teo y, thai c, thera m,
titanji v, toure o, troye-blomberg m, usen s, uyoga s, vanderwal a, wangai h,
watson r, williams t, wilson m, wrigley r, yafi c, yamoah l.

author information: 
(1)kemri/wellcome trust research programme, kilifi, kenya; wellcome centre for
human genetics, university oxford, oxford, uk.
(2)kemri/wellcome trust research programme, kilifi, kenya.
(3)london school hygiene & tropical medicine, london, uk; centro de
estatística e aplicações da universidade de lisboa, lisbon, portugal.
(4)london school hygiene & tropical medicine, london, uk.
(5)wellcome centre human genetics, university oxford, oxford, uk.
(6)kemri/wellcome trust research programme, kilifi, kenya; wellcome sanger
institute, cambridge, uk.
(7)unaffiliated researcher [researcherid: l-3155-2013].
(8)kemri/wellcome trust research programme, kilifi, kenya; department of
medicine, imperial college, st mary's hospital, london, uk.
(9)wellcome centre human genetics, university oxford, oxford, uk; big data
institute, university oxford, oxford, uk; wellcome sanger institute,
cambridge, uk.
(10)kemri/wellcome trust research programme, kilifi, kenya; department of
medicine, imperial college, st mary's hospital, london, uk. electronic address:
tom.williams@imperial.ac.uk.

background: human genetic factors important determinants malaria risk. 
investigated associations multiple candidate polymorphisms-many related
to structure function red blood cells-and risk severe plasmodium
falciparum malaria specific phenotypes, including cerebral malaria,
severe malaria anaemia, respiratory distress.
methods: case-control study kilifi county, kenya. recruited as
cases children presenting severe malaria high-dependency ward of
kilifi county hospital. included controls infants born local
community aug 1, 2006, sept 30, 2010, part genetics
study. tested associations range candidate malaria-protective
genes risk severe malaria specific phenotypes. used a
permutation approach account multiple comparisons polymorphisms
and severe malaria. judged p values less 0·005 significant the
primary analysis association candidate genes severe malaria.
findings: june 11, 1995, june 12, 2008, 2244 children severe
malaria recruited study, 3949 infants included controls. 
overall, 263 (12%) 2244 children severe malaria died hospital,
including 196 (16%) 1233 cerebral malaria. investigated 121
polymorphisms 70 candidate severe malaria-associated genes. found
significant associations risk severe malaria overall and
polymorphisms 15 genes locations, related red blood
cells: abo, atp2b4, arl14, cd40lg, frem3, inpp4b, g6pd, hba (both hba1 hba2),
hbb, il10, lphn2 (also known adgrl2), loc727982, rps6kl1, cand1, gnas.
combined, genetic associations accounted 5·2% variance risk
for developing severe malaria among individuals general population. we
confirmed established associations severe malaria sickle-cell trait
(odds ratio [or] 0·15, 95% ci 0·11-0·20; p=2·61 × 10-58), blood group (0·74,
0·66-0·82; p=6·26 × 10-8), -α3·7-thalassaemia (0·83, 0·76-0·90;
p=2·06 × 10-6). also found strong associations overall risk severe 
malaria polymorphisms atp2b4 (or 0·76, 95% ci 0·63-0·92; p=0·001) and
frem3 (0·64, 0·53-0·79; p=3·18 × 10-14). association frem3 could be
accounted linkage disequilibrium complex structural mutation within
the glycophorin gene region (comprising gypa, gypb, gype) encodes for
the rare dantu blood group antigen. heterozygosity dantu associated 
risk severe malaria (or 0·57, 95% ci 0·49-0·68; p=3·22 × 10-11), was
homozygosity (0·26, 0·11-0·62; p=0·002).
interpretation: atp2b4 dantu blood group antigen associated with
the structure function red blood cells. atp2b4 codes plasma membrane
calcium-transporting atpase 4 (the major calcium pump red blood cells) the
glycophorins ligands parasites invade red blood cells. future work
should aim uncovering mechanisms polymorphisms result
in severe malaria protection investigate implications these
associations wider health.
funding: wellcome trust, uk medical research council, european union, and
foundation national institutes health part bill & melinda
gates grand challenges global health initiative.

copyright © 2018 author(s). published elsevier ltd. open access
article cc 4.0 license. published elsevier ltd.. rights
reserved.

doi: 10.1016/s2352-3026(18)30107-8 
pmcid: pmc6069675
pmid: 30033078  [indexed medline]

